Review

Epigenetic Perspective in Schizophrenia: DNA Methylation Patterns

Volume: 31 Number: 3 September 30, 2022
TR EN

Epigenetic Perspective in Schizophrenia: DNA Methylation Patterns

Abstract

Schizophrenia is a mental disorder characterized by delusions, hallucinations and various behavioral disorders. Affecting approximately 1% of the world's population, schizophrenia not only affects patients, but also other members of the society. Genetic and environmental factors play roles in the etiology of the disorder.
Genetics, neurodevelopmental disorder, drug use, urban life, alone or together can be counted as the factors that cause the disorder. Despite increasing studies in recent years, the factors causing the formation of schizophrenia have not been fully clarified and more research is needed. Although genetic factors are risk factors for schizophrenia, it is thought that some environmental factors affect the emergence of the disorder. Epigenetic mechanisms regulate gene functions without changing the nucleotide sequence of DNA. DNA methylation is associated with schizophrenia, and methylation status studies have been conducted in many schizophrenia candidate genes. Examination of DNA methylation states will contribute significantly to psychiatric research.
In this review, data published in global databases obtained from DNA methylation studies related with schizophrenia are summarized and their importance in schizophrenia is briefly discussed.

Keywords

schizophrenia , epigenetics , environmental factors , DNA methylation

References

  1. REFERENCES 1. Andreasen NC. Schizophrenia: the fundamental questions. Brain Res Brain Res Rev. Mar 2000;31(2-3):106-112.
  2. 2. Wong AH, Van Tol HH. Schizophrenia: from phenomenology to neurobiology. Neurosci Biobehav Rev. May 2003;27(3):269-306.
  3. 3. Winship IR, Dursun SM, Baker GB, et al. An Overview of Animal Models Related to Schizophrenia. Can J Psychiatry. Jan 2019;64(1):5-17.
  4. 4. Moran P, Stokes J, Marr J, et al. Gene x Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models. Neural Plast. 2016;2016:2173748.
  5. 5. Modai S, Shomron N. Molecular Risk Factors for Schizophrenia. Trends Mol Med. Mar 2016;22(3):242-253.
  6. 6. Andreasen NC. Schizophrenia: the fundamental questions. Brain Research Reviews. Mar 2000;31(2-3):106-112.
  7. 7. Khavari B, Cairns MJ. Epigenomic Dysregulation in Schizophrenia: In Search of Disease Etiology and Biomarkers. Cells. Aug 5 2020;9(8).
  8. 8. Alelu-Paz R, Gonzalez-Corpas A, Ashour N, et al. DNA methylation pattern of gene promoters of major neurotransmitter systems in older patients with schizophrenia with severe and mild cognitive impairment. International Journal of Geriatric Psychiatry. Jun 2015;30(6):558-565.
  9. 9. Hoffman GE, Bendl J, Voloudakis G, et al. CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder. Sci Data. Sep 24 2019;6(1):180.
  10. 10. Maric NP, Svrakic DM. Why schizophrenia genetics needs epigenetics: a review. Psychiatr Danub. Mar 2012;24(1):2-18.
AMA
1.Karaaslan E, Kartalcı Ş, Acar C. Epigenetic Perspective in Schizophrenia: DNA Methylation Patterns. Arşiv Kaynak Tarama Dergisi. 2022;31(3):204-212. doi:10.17827/aktd.1096901